There may be important differences between the available GnRH antagonists, in terms of which patients they can be used in and how and what level of additional monitoring or precaution is recommended or required. Further information will be included in each licensed product’s SmPC, and this may include:1,2
- Recommended lipid monitoring
- Use in patients with hepatic impairment and any recommended liver enzyme monitoring
- Use and any recommended monitoring in patients with renal impairment
- Precautions for women with CVD or family history of CVD
